Nyrada Inc - Annual Report 2021

NYRADA INC (ASX:NYR) 50 9. Issued capital (continued) Options on issue The following share-based payment arrangements were issued in the current reporting period: No. of options. Grant date Expiry date Grant date fair value Vesting date/ Expected Vesting Date Exercise Price 600,000 18/01/2021 18/01/2024 $0.1054 18/01/2022 TBC 1 600,000 18/01/2021 18/01/2025 $0.1166 18/01/2023 TBC 1 600,000 18/01/2021 18/01/2026 $0.1260 18/01/2024 TBC 1 1,200,000 24/02/2021 3 years from vesting $0.1667 24/02/2021 TBC 2 4,000,000 29/06/2021 29/06/2026 $0.1703 29/06/2021 $0.40 2,000,000 29/06/2021 29/06/2026 $0.1457 29/06/2021 $0.60 2,000,000 29/06/2021 29/06/2026 $0.1210 29/06/2021 $0.90 1. The exercise price is the higher of • 100% of the Fair Market Value (as defined in the Company’s Stock Incentive Plan) of the Shares on the date that Option is granted; and • an amount equal to 120% of the volume weighted average price of the CDIs for the period of 10 trading days immediately prior to the date on which that Option vests. • An exercise price of $0.23 was used for the purpose of the fair value calculation at grant date. 2. The exercise price is the higher of • 100% of the Fair Market Value (as defined in the Company’s Stock Incentive Plan) of the Shares on the date that Option is granted; and • an amount equal to 120% of the volume weighted average price of the CDIs for the period of 10 trading days immediately prior to the date on which that Option vests. An exercise price of $0.33 was used for the purpose of the fair value calculation at grant date. • As at 30 June, the known range of exercise price of options is between $0.20 and $0.90 and of nil for performance common stock (refer note c). The weighted average remaining contractual life of options and performance common stock is 1,361 days.